Delivery Order SPE2DB20D9223-SPE2DB22FV80J
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,923.36 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product, with an ultimate completion date of April 25, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, valued at up to $4,999,999 and held by DMS...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $7,308.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, with a period of performance through May 13, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999, which allows the DLA to issue delivery orders for a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,335.76, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a biologic medication. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- This federal contract award for $1,461.70 was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The award is a delivery order under DMS Pharmaceutical Group's $4,999,999 indefinite delivery contract with DLA for a broad range of pharmaceutical products, including prescription drugs, biologics, and medical supplies to support the recurring needs of military health facilities globally. The contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,759.56, is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,084.36 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Actemra 400 mg/20 ml vials. This firm fixed-price delivery order is not associated with a set-aside designation and carries an ultimate completion date of August 25, 2025. The award represents a single line item delivery under DMS Pharmaceutical Group's...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,192.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a biologic medication used to treat certain autoimmune conditions. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with DLA, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a $4,620.78 firm fixed-price delivery order under the DLA's SPE2DB program, an indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. The delivery order is for the pharmaceutical product ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. DMS Pharmaceutical...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,144.80 firm fixed-price contract is for the delivery of 4555870895 - ACTEMRA 400 MG/20 ML VIAL 20ML to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,770.08 firm fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- SPE2DB20D9223Indefinite Delivery Contract
- SPE2DB20D9223-SPE2DB22FV80JDelivery Order
The Department of Defense, through the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order worth $14,003.64 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The delivery order is for 4556446218 - ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialized pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure this and other direct federal awards across various medical product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 2/17/22 |